Evidence map›Paper›PMID 36482490›Full record

ReviewAddiction science & clinical practice2022

Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities-overview and commentary.

Nickolas D Zaller, Margaret M Gorvine, Jon Ross, Shannon Gwin Mitchell, Faye S Taxman, David Farabee

Abstract readReview
In one paragraph

Review in Addiction science & clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nickolas D ZallerUniversity of Arkansas for Medical Sciences, College of Public Health, Little Rock, AR, USA. ndzaller@uams.edu.ORCID 0000-0002-7363-3437
Margaret M GorvineUniversity of Arkansas for Medical Sciences, College of Public Health, Little Rock, AR, USA.
Jon RossTASC, Inc. (Treatment Alternatives for Safe Communities), Chicago, IL, USA.
Shannon Gwin MitchellFriends Research Institute, Baltimore, MD, USA.
Faye S TaxmanGeorge Mason University, Schar School of Policy and Government, Fairfax, VA, USA.
David FarabeeNew York University, School of Medicine, New York, NY, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Technical Assistance CoreU2CDA050097 · NIDA · GEORGE MASON UNIVERSITY · PI Danielle Sheldon Rudes · 2019 to 2026
$37.0M
Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adultsU01DA047982 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FARABEE, DAVID J, GRYCZYNSKI, JAN · 2019 to 2024
$20.3M
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatmentUG1DA050077 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI BLUE, THOMAS, GORDON, MICHAEL SCOTT · 2019 to 2023
$11.6M
The role of prisons in community spread of COVID-19: Disparate epidemiologic profiles in rural, racial/ethnic minority, and low socioeconomic US countiesU54MD002329 · NIMHD · UNIV OF ARKANSAS FOR MED SCIS · PI RACZYNSKI, JAMES M · 2017 to 2022
$7.7M
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance UptakeOT2OD034479 · OD · GEORGE MASON UNIVERSITY · PI TAXMAN, FAYE S · 2022 to 2023
$5.6M
Advancing Health Disparities Research in Aging: The Aging Research in Criminal Justice & Health (ARCH) NetworkR24AG065175 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LISA C BARRY, BRIE A WILLIAMS · 2019 to 2026
$3.3M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR003107NIA NIH HHS R24 AG065175NIDA NIH HHS U01 DA047982NIDA NIH HHS U2C DA050097NIDA NIH HHS UG1 DA050077NIH HHS OT2 OD034479NIMHD NIH HHS U54 MD002329
6 · The paper itself

Abstract

This manuscript is the product of the authors' discussions, literature overview, and consultation with experts in the field, and identifies important gaps in the evidence base for substance use disorder (SUD) treatment effectiveness within criminal justice (CJ) settings. Lacking from the extant literature are longitudinal investigations of treatment related outcomes during and after incarceration. Such studies could provide rich contextual data about treatment delivery and effectiveness across the CJ continuum, and would provide important insight into individual characteristics (e.g., motivation, treatment modality preferences, treatment completion rates, etc.) as well as institutional and environmental factors (e.g., appropriate staffing, space limitations for individual treatment sessions, distribution of medications, etc.). We also identified the importance of reproducibility within CJ research, and the unfortunate reality of too many single studies conducted in single (or relatively few) correctional facilities. Some of this has been because the studies designed to produce that evidence are not prioritized for funding, which has continually placed researchers in a position where we cannot make firm conclusions or recommendations based on available evidence. The importance of replicating the foundational studies in this field cannot be overstated. We hope this article spurs other researchers to join in the healthy process of questioning the existing state of the CJ-based SUD treatment research, what should be re-examined, and how we can lay a stronger foundation for the future.

Indexed as

ResearchSubstance-Related DisordersHumansReproducibility of ResultsCriminal justiceSubstance use disorderTreatment

Identifiers

PMID36482490
PMCPMC9733039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.